Imadul I.

ACTING HEAD, PHARMACEUTICAL ANALYSIS

United States of America
EN

Over 20+ years of Chemistry Research, drug design, discovery and development experience in CNS, Oncology, Immunology and Cardiovascular areas 2. Demonstrated scientific ability and leadership to del...see more

  • Pharmaceutical

350

/hr
  • Pre-vetted expert
  • Confirmed hourly rate
  • Available on short notice

Experience

ACTING HEAD, PHARMACEUTICAL ANALYSIS

King Abdullah International Medical Research Center (كيمارك KAIMRC)
2 years
Current position
Aug 2020 - Present

DEPUTY DIRECTOR, DRUG DISCOVERY AND SR. RESEARCH SCIENTIST

King Abdullah International Medical Research Center (كيمارك KAIMRC)
6 years
Current position
Jan 2016 - Present
-Drug Discovery in Core Therapeutic Areas - Establishing Medicinal Chemistry labs and group to do basic research - Establishing collaboration with academic institutions in KSA and Abroa...see more

Sr. Consultant

Bayside Pharma
1 year
Aug 2014 - Jan 2016
• Chemistry/Medicinal Chemistry/Drug Discovery & Development • Chemistry Manufacturing & Control (CMC), Regulatory Compliance for Pharmaceutical Products (UC Berkeley, One Semester)

Director of Research-Medicinal Chemistry

Bristol-Myers Squibb Research Centre at Biocon, Bangalore, India
4 years
Dec 2009 - Dec 2013
• Responsible for optimization of clinical candidates (Hit to FTIH) in various drug discovery programs with emphasis on CNS drug Discovery. Effective management of resources. • Directl...see more

Investigator

GlaxoSmithKline
3 years
May 2007 - Mar 2010
•Participated in the design and synthesis of therapies for treatment of Alzhiemer and Dementia. •Contributing to the discovery of immunophilin inhibitors to treat CNS diseases. •Contin...see more

Scientist III

Bayer Health Care
10 years
Sep 1996 - Feb 2007
The research was carried out at Berlex Biosciences (US Subsudiary of Schering AG, acquired by Bayer AG) •Designed and synthesized Carboxypeptidase-B inhibitors (TAFI) for the treatment ...see more

Scientist

Lundbeck USA
3 years
Mar 1993 - Aug 1996
The research was carried out at Synaptic Pharmaceuticals acquired by Lundbeck •Involved in design and synthesis of the first small molecule, nonpeptide, selective Neuropeptide Y5 antago...see more

Post Doctoral Research Scientist

Pfizer
2 years
Apr 1991 - Apr 1993
Upjohn was later acquired and this research was carried out at Upjohn before its acquisition by Pfizer. Involved in the resarch and development of Antiviral and antitumor agents. Publis...see more

RA

Indian Institute of Technology, Kanpur
2 years
Dec 1984 - Dec 1986
Research in development of synthetic methodology and natural product synthesis

Industries, roles and expertise

Industry experience

  • Pharmaceutical

Expertise

  • Organic Chemistry
  • Oncology
  • Cancer
  • Cancer Research
  • Cardio Vascular Diseases